Rutgers leading coronavirus therapeutic clinical trial

(Rutgers University) Rutgers is leading a clinical trial assessing the combination of nitazoxanide, ribavirin and hydroxychloroquine to treat people 21 or older who are infected with SARS-CoV-2 and are asymptomatic or mildly symptomatic.
Source: EurekAlert! - Infectious and Emerging Diseases - Category: Infectious Diseases Source Type: news